Neumarkt in der Oberpfalz, 2 January 2019 – On 1 January 2019 Bionorica SE strengthened its management team with the assignment of Dr Hanke Wohlers as Director of Product Supply. ‘Dr Hanke Wohlers advanced us and his unit significantly. Moreover he enables Bionorica to reach the high growth targets on the production side’, says Professor Dr Michael A Popp, Chairman of the Executive Board at Bionorica SE.

Dusseldorf, 2 March 2018 – Bionorica is looking back at a successful fiscal 2017. The pharmaceutical company enjoyed another increase in sales to EUR 297.6 million. This represents a substantial increase of 17.6 percent (2016: EUR 253.1 million). These were the figures provided by Professor Michael A. Popp, owner and CEO of Bionorica SE, during the presentation of the company's annual report.

PyeongChang/Neumarkt in the Oberpfalz, 2 February 2018 – A severe cold in the middle of a competition at the Olympics - what can be done to treat it without being suspected of doping? A simple question, but one that is frequently asked by the 180 athletes in the German Olympic Sports Confederation team. The medication must be effective, but not included on any of the red lists. This is why the German Olympic team physicians have been relying on medicinal products with herbal active ingredients for many years, also at the Olympic Games.

Innsbruck, 18 October 2017 – The Michael Popp Institute for Plant-based Active Ingredient Research, which was established today at the University of Innsbruck, is dedicated to learning more about the healing power of plants and producing effective herbal medicines through cutting-edge research. The two endowed professorships at the LFU (Leopold-Franzens University Innsbruck) will be funded by the State of Tyrol and the Michael A. Popp Nature Science Foundation. The costs for the research establishment, which will employ around 20 scientists and students, will be in the region of EUR 5 million over the next five years.

Taipeh/Neumarkt, 16 August 2017 – At the Olympic Games, or at the Summer Universiade taking place this month in the Taiwan capital Taipei, Germany's top athletes are trusting in Bionorica's effective herbal medicines. When the 130 university athletes fly to Asia for the event, their team doctors will have five different cold remedies from Bionorica in their luggage.

Voronezh/Neumarkt, 10 July 2017 – With an official groundbreaking ceremony, pharmaceutical company Bionorica today marked the start of construction for a facility in Voronezh, Russia. "Russia is our largest international market and we enjoy a close 20-year friendship with the people here," said Professor Michael A. Popp, CEO and proprietor of Bionorica SE, in Voronezh. "Through this around €40 million investment in building our own production facility here we are reinforcing our commitment to the country and our enormous confidence in a prosperous future."

Neumarkt, Düsseldorf, 2/3 March 2017 – With a significant increase of 5.7 per cent in pharmacy sales(1) in Germany Bionorica once again enjoyed above-average growth compared with the competition in the last fiscal year 2016 (pharmaceutical market + 1.9 per cent(2), OTC market + 2.3 per cent(3)).